ABILIFY 1 mg/mL, solution buvable
solution buvable
orale
Autorisation active
Procédure centralisée
Commercialisée
10/28/2005
OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!